Angela Elma Edwina
Overview
Explore the profile of Angela Elma Edwina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Edwina A, Koziolek M, Steenackers N, Vanuytsel T, Lopez Marmol A, Matthys C, et al.
Int J Pharm
. 2024 Dec;
669():125016.
PMID: 39645061
Introduction: Gastrointestinal (GI) changes may alter drug absorption, potentially impacting both efficacy and safety of oral pharmacotherapy. However, the GI physiology is rarely studied in the aging population. This study...
2.
Edwina A, Dreesen E, Gijsen M, van den Hout H, Desmet S, Flamaing J, et al.
Drugs Aging
. 2024 Aug;
41(9):753-762.
PMID: 39158762
Introduction: Older adults face a higher risk of vancomycin-related toxicity given their (patho)-physiological changes, making early management of supratherapeutic exposure crucial. Yet, data on vancomycin exposure in older adults is...
3.
Edwina A, Dreesen E, Hias J, Koch B, Van den Eede N, Pauwels S, et al.
AAPS J
. 2024 Feb;
26(1):23.
PMID: 38302833
Special populations, like geriatric patients, experience altered paracetamol pharmacokinetics (PK), complicating pain management. More PK research is essential to optimize paracetamol (acetaminophen) dosing. Yet, the reference method ultra-performance liquid chromatography-tandem...
4.
Demeester C, Robins D, Edwina A, Tournoy J, Augustijns P, Ince I, et al.
Eur J Pharm Sci
. 2023 Jun;
188:106496.
PMID: 37329924
The older population consisting of persons aged 65 years or older is the fastest-growing population group and also the major consumer of pharmaceutical products. Due to the heterogenous ageing process,...
5.
Edwina A, Koch B, Muller A, Al Jalali V, Matzneller P, Zeitlinger M, et al.
Eur J Clin Pharmacol
. 2023 Apr;
79(6):775-787.
PMID: 37060459
Purpose: A population pharmacokinetic model of fosfomycin was developed in healthy volunteers after intravenous administration, and different dosing regimens were evaluated in terms of the probability of target attainment for...
6.
Edwina A, Dia N, Dreesen E, Vanassche T, Verhamme P, Spriet I, et al.
Clin Pharmacokinet
. 2023 Mar;
62(3):351-373.
PMID: 36862336
Older adults, the fastest growing population, represent almost 50% of all users of direct oral anticoagulants (DOACs). Unfortunately, we have very little relevant pharmacological and clinical data on DOACs, especially...
7.
Oktora M, Edwina A, Denig P
Front Public Health
. 2022 Feb;
10:795043.
PMID: 35223732
Background: Deprescribing requires patients' involvement and taking patients' attitudes toward deprescribing into account. To understand the observed variation in these attitudes, the influence of contextual-level factors, such as country or...